05Jul 2021
How COVID-19 disrupts glycometabolic control

How COVID-19 disrupts glycometabolic control

Coronavirus disease 2019 (COVID-19) is associated with hyperglycaemia. A study published in Nature Metabolism now shows how hyperglycaemia develops in a cohort of 551 patients hospitalized with COVID-19 in Italy. “We started from a clinical observation: in patients hospitalized for COVID-19, there is a huge rate of new-onset hyperglycaemia,” explains corresponding author Paolo Fiorina. “In these patients, clinical outcomes are the poorest, with more requirement for ventilation, need of ICU and longer length of hospitalization...

  • #endo-diabetology

Like

Save

Share